Prelude Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-38,159
Closed -$731K 1303
2025
Q1
$731K Sell
38,159
-59,531
-61% -$1.14M 0.06% 330
2024
Q4
$3.52M Buy
97,690
+29,580
+43% +$1.07M 0.22% 71
2024
Q3
$2.89M Buy
68,110
+30,189
+80% +$1.28M 0.17% 121
2024
Q2
$1.53M Sell
37,921
-38,109
-50% -$1.54M 0.11% 208
2024
Q1
$2.69M Buy
76,030
+68,105
+859% +$2.41M 0.14% 142
2023
Q4
$234K Buy
+7,925
New +$234K 0.02% 745
2023
Q2
Sell
-6,514
Closed -$265K 1254
2023
Q1
$265K Sell
6,514
-3,159
-33% -$128K 0.02% 623
2022
Q4
$435K Sell
9,673
-5,544
-36% -$249K 0.02% 552
2022
Q3
$728K Buy
15,217
+6,081
+67% +$291K 0.03% 510
2022
Q2
$541K Sell
9,136
-7,101
-44% -$420K 0.02% 650
2022
Q1
$1.89M Buy
16,237
+12,392
+322% +$1.44M 0.05% 277
2021
Q4
$579K Buy
3,845
+326
+9% +$49.1K 0.01% 714
2021
Q3
$420K Sell
3,519
-7,726
-69% -$922K 0.01% 734
2021
Q2
$1.1M Buy
+11,245
New +$1.1M 0.03% 431
2020
Q3
Sell
-1,031
Closed -$102K 1833
2020
Q2
$102K Buy
+1,031
New +$102K 0.01% 661
2020
Q1
Sell
-4,696
Closed -$280K 1541
2019
Q4
$280K Buy
4,696
+4,502
+2,321% +$268K 0.01% 451
2019
Q3
$11K Buy
194
+82
+73% +$4.65K ﹤0.01% 1011
2019
Q2
$7K Sell
112
-10,938
-99% -$684K ﹤0.01% 1078
2019
Q1
$702K Sell
11,050
-6,422
-37% -$408K 0.04% 218
2018
Q4
$663K Buy
17,472
+16,391
+1,516% +$622K 0.04% 242
2018
Q3
$46K Sell
1,081
-1,390
-56% -$59.1K ﹤0.01% 833
2018
Q2
$54K Sell
2,471
-6,369
-72% -$139K ﹤0.01% 866
2018
Q1
$44K Buy
8,840
+8,803
+23,792% +$43.8K ﹤0.01% 988
2017
Q4
$0 Sell
37
-40
-52% ﹤0.01% 1573
2017
Q3
$1K Buy
+77
New +$1K ﹤0.01% 1437
2015
Q2
Sell
-80
Closed -$10K 1940
2015
Q1
$10K Buy
+80
New +$10K ﹤0.01% 1751